Analysts raise MetLife price targets to $105 and $103
Keefe, Bruyette & Woods, Jefferies, and Evercore ISI Group have all raised their price targets for MetLife, reflecting a positive revised outlook on the insurer's valuation.
*this image is generated using AI for illustrative purposes only.
Keefe, Bruyette & Woods analyst Ryan Krueger has maintained an Outperform rating on MetLife (NYSE: MET) and raised the price target to $105 from $98. This adjustment reflects a revised outlook on the insurer's valuation and potential for stock appreciation. Separately, Jefferies analyst Suneet Kamath has maintained a Buy rating on MetLife and raised the price target to $103 from $97. Additionally, Evercore ISI Group analyst Thomas Gallagher has maintained an In-Line rating on MetLife and raised the price target to $103 from $96.
Analyst Ratings and Price Targets
The endorsements from all three firms come with increased price objectives, signaling confidence in the company's stock performance.
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Ryan Krueger | Outperform | $98 | $105 |
| Jefferies | Suneet Kamath | Buy | $97 | $103 |
| Evercore ISI Group | Thomas Gallagher | In-Line | $96 | $103 |
The revised targets suggest potential upside from current trading levels.
What specific factors are driving the consensus among analysts to raise MetLife's price targets?
How might MetLife's upcoming earnings report impact the stock's trajectory toward these new targets?
What are the potential risks that could prevent MetLife from achieving the revised price objectives?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
